Hims & Hers reported a double beat in Q4, but faced an 18% stock drop after hours. Read why this drop is a good opportunity ...

Hims & Hers' acquisition of Trybe Labs broadens its treatment range and enhances its competitive edge through increased data ...

Hims & Hers Health shares jumped some 20% to a record high on Wednesday following the announcement that it acquired lab ...

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of US-based Trybe Labs. This strategic move is set to enhance the company ...

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Online health and wellness company Hims & Hers reported fourth-quarter earnings that beat Wall Street analysts' expectations ...

Hims & Hers Health Inc (NYSE:HIMS) shares are soaring Wednesday after the company announced plans to introduce at-home lab ...

Investing.com -- Shares of Hims & Hers Health Inc. (NYSE:HIMS) surged 15.7% on Wednesday following the announcement that the company has acquired Trybe Labs, an at-home lab testing facility.

Hims & Hers, a health and wellness platform, is set to introduce at-home lab testing capabilities through the acquisition of ...

New service will enable blood testing for hormone levels, cardiac risk, thyroid function, and more using a blood lancet.

Hims & Hers is introducing at-home laboratory testing, expanding its platform to offer deeper health insights and more ...